Olema Pharmaceuticals (OLMA) Operating Leases (2021 - 2025)
Olema Pharmaceuticals (OLMA) posted quarterly Operating Leases of $69000.0 for Q4 2025, down 73.15% year-over-year from $257000.0 in Q4 2024, and down 77.74% quarter-over-quarter from $310000.0 in Q3 2025.
Olema Pharmaceuticals (OLMA) Operating Leases (2021 - 2025) Analysis & Trends
Olema Pharmaceuticals (OLMA) has reported Operating Leases for 5 consecutive years, with $69000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Leases fell 73.15% year-over-year to $69000.0; the TTM figure through Dec 2025 stood at $69000.0 (down 73.15% YoY), while the FY2025 annual figure was $69000.0, down 73.15% from the prior year.
- Operating Leases slipped to $69000.0 in Q4 2025 per OLMA's latest filing, from $310000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $2.4 million in Q4 2021 and bottomed at $69000.0 in Q4 2025.
- Historically, Operating Leases has averaged $1.1 million across 5 years, with a median of $1.2 million in 2023.
- Annual changes were most pronounced in 2023 — Operating Leases slipped 2.69% — and 2025, when it plunged 89.32%.
- Olema Pharmaceuticals' Operating Leases stood at $2.4 million in 2021, then slumped by 34.27% to $1.5 million in 2022, then dropped by 7.81% to $1.4 million in 2023, then plunged by 82.02% to $257000.0 in 2024, then tumbled by 73.15% to $69000.0 in 2025.
- Business Quant data shows OLMA's Operating Leases at $69000.0 in Q4 2025, $310000.0 in Q3 2025, and $602000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Olema Pharmaceuticals | 930.10 Mn | 930.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 69,000.00 |
| Sep 30, 2025 | 310,000.00 |
| Jun 30, 2025 | 602,000.00 |
| Mar 31, 2025 | 123,000.00 |
| Dec 31, 2024 | 257,000.00 |
| Sep 30, 2024 | 562,000.00 |
| Jun 30, 2024 | 859,000.00 |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 1.43 Mn |
| Sep 30, 2023 | 1.70 Mn |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 1.38 Mn |
| Dec 31, 2022 | 1.55 Mn |
| Sep 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 2.01 Mn |
| Mar 31, 2022 | 2.16 Mn |
| Dec 31, 2021 | 2.36 Mn |